Skip to content

Comparing two types of prf for better gum healing and bone protection after dental implant placement.

Comparitive evaluation of effectiveness of titanium platelet rich fibrin and leucocyte platelet rich fibrin on peri-implant soft tissue and crestal bone height after implant placement: a randomized clinical trial - nil

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/102479
Enrollment
30
Registered
2026-01-29
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: TITANIUM PRF: T-PRF will be placed in the osteotomy site before implant placement Control Intervention1: LEUCOCYTE PRF: L-PRF will be placed in the osteotomy site before implant placeme

Sponsors

Natwar Singh
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age group 18-65 years. Subjects who are systemically healthy. Subjects having sufficient inter-arch space , normal maxillo-mandibular relationship and the absence of TMJ pathosis. Subjects with sufficient bone thickness and height that is suitable for the proposed implants Patients should be physically and psychologically able to tolerate conventional implant surgical protocol.

Exclusion criteria

Exclusion criteria: Subjects with any systemic disorders such as cardiovascular disease, hepatobiliary disease, diabetes, thyroid and parathyroid abnormalities. Subjects currently on antibiotics, steroids or hormonal therapy. Pregnant women, lactating women. Smokers Subjects having blood disease that may prevent PRF formation.

Design outcomes

Primary

MeasureTime frame
CRESTAL BONE LEVEL, BONE DENSITY, PERI IMPLANT PROBING DEPTH, WOUND HEALING INDEX, GINGIVAL INDEXTimepoint: 0 AND 03 MONTHS

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactNatwar Singh

RUHS College of Dental Sciences (GDC), Jaipur

sharmisthavijay@yahoomail.com9414045444

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026